Infringement action filed 16 Nov 2022 in the United States District Court for the Eastern District of California and closed 27 Nov 2023, with 2 patents asserted. Recorded basis of termination: dismissed with prejudice.
Method for conducting an autocatalytic reaction in plugs in a microfluidic system · Method for conducting reactions involving biological molecules in plugs in a microfluidic system
Source: Patsnap Litigation Data. Case 3:22-cv-07205, United States District Court for the Eastern District of California.Open this record in Eureka
Patsnap Eureka
Check this patent against your own product
Prior art, claim scope, infringement exposure and design-around routes. Every answer cites the records behind it.
The present invention provides microfabricated substrates and methods of conducting reactions within these substrates. The reactions occur in plugs transported in the flow of a carrier-fluid.
The present invention provides microfabricated substrates and methods of conducting reactions within these substrates. The reactions occur in plugs transported in the flow of a carrier-fluid.
Source: case record + Patsnap company data. Attorney names appear as recorded in the docket.Compare both portfolios
Outcome
Basis of termination
From the record · verbatim
"Plaintiffs Bio-Rad Laboratories, Inc. and the University of Chicago (“Plaintiffs”), and together with Defendant GigaGen, Inc. (“GigaGen”) (collectively, “the Parties”), by and through their undersigned counsel of record, hereby stipulate as follows: WHEREAS, Plaintiffs have asserted the following two causes of action against GigaGen (D.I. 1): First Cause of Action: Infringement of U.S. Patent No. 8,329,407; and Second Cause of Action: Infringement of U.S. Patent No. 8,304,193. WHEREAS, GigaGen has not asserted any counterclaims; IT IS STIPULATED AND AGREED, by and between the Parties through their undersigned counsel, and subject to approval of the Court, that (1) Plaintiffs’ First and Second Causes of Action are dismissed with prejudice; and (2) each Party shall bear its own costs and attorneys’ fees. IT IS SO STIPULATED, through Counsel of Record."
Case 3:22-cv-07205 · E.D. Cal. · closed 27 November 2023
Source: case record, verbatim. The quoted paragraph is the basis-of-termination text as filed.
Related cases
Three questions this record usually leads to. Each one runs against the full litigation and patent corpus, and cites what it finds.
3:22-cv-07205 is a patent infringement action brought by Bio-Rad Laboratories against GigaGen, Inc., filed on 16 Nov 2022 in the United States District Court for the Eastern District of California. The case closed on 27 November 2023.
Which patents were asserted in 3:22-cv-07205?
US8304193B2 (“Method for conducting an autocatalytic reaction in plugs in a microfluidic system”), assigned to THE UNIVERSITY OF CHICAGO, currently inactive; US8329407B2 (“Method for conducting reactions involving biological molecules in plugs in a microfluidic system”), assigned to THE UNIVERSITY OF CHICAGO, currently inactive. The record also lists Method for conducting an autocatalytic reaction in plugs in a microfluidic system and Method for conducting reactions involving biological molecules in plugs in a microfluidic system.
How was case 3:22-cv-07205 terminated?
The recorded basis of termination is dismissed with prejudice. The termination text reads: "Plaintiffs Bio-Rad Laboratories, Inc. and the University of Chicago (“Plaintiffs”), and together with Defendant GigaGen, Inc. (“GigaGen”) (collectively, “the Parties”), by and through their undersigned counsel of record, hereby stipulate as follows: WHEREAS, Plaintiffs have asserted the following two causes of action against GigaGen (D.I. 1): First Cause of Action: Infringement of U.S. Patent No. 8,329,407; and Second Cause of Action: Infringement of U.S. Patent No. 8,304,193. WHEREAS, GigaGen has not asserted any counterclaims; IT IS STIPULATED AND AGREED, by and between the Parties through
What does dismissal with prejudice mean?
A dismissal with prejudice permanently ends the claims that were filed, so the same claims cannot be brought again against that defendant. It is the usual form when the parties have settled.
How long did case 3:22-cv-07205 take?
376 calendar days, from filing on 16 Nov 2022 to closure on 27 November 2023.
Who were the attorneys and the judge in 3:22-cv-07205?
Derek C. Walter, Edward Robert Reines and Gregg Thomas Stephenson are recorded as counsel for plaintiff Bio-Rad Laboratories. Daralyn J. Durie, Eugene Novikov, Jennifer J. Shih, Joyce C. Li, Michael A. Jacobs, Nate Tan and Nicholas Rylan Fung appear for defendant GigaGen.
Answers reproduce fields from the case record for 3:22-cv-07205 and do not constitute legal advice.Ask your own question
Disclaimer. This page reproduces publicly available court docket data for case 3:22-cv-07205 and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Docket data has limits. Records are drawn from a snapshot and may lag the live docket. Sealed filings, amended complaints, counterclaims and post-closure motions may not be reflected. Party names, attorney names and firm affiliations are reproduced as recorded and may contain omissions. Where a field is absent from the record, this page marks it as not recorded rather than inferring a value.
No characterisation of the parties or the outcome. This page reports what the record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed.
No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.
